6hcl: Difference between revisions
No edit summary |
No edit summary |
||
| Line 1: | Line 1: | ||
==Crystal structure of a MFS transporter with Ligand at 2.69 Angstroem resolution== | |||
<StructureSection load='6hcl' size='340' side='right'caption='[[6hcl]], [[Resolution|resolution]] 2.50Å' scene=''> | |||
== Structural highlights == | |||
<table><tr><td colspan='2'>[[6hcl]] is a 2 chain structure. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=6HCL OCA]. For a <b>guided tour on the structure components</b> use [http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=6HCL FirstGlance]. <br> | |||
</td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat"><scene name='pdbligand=2OP:(2S)-2-HYDROXYPROPANOIC+ACID'>2OP</scene>, <scene name='pdbligand=BNG:B-NONYLGLUCOSIDE'>BNG</scene></td></tr> | |||
<tr id='related'><td class="sblockLbl"><b>[[Related_structure|Related:]]</b></td><td class="sblockDat">[[6g9x|6g9x]]</td></tr> | |||
<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=6hcl FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=6hcl OCA], [http://pdbe.org/6hcl PDBe], [http://www.rcsb.org/pdb/explore.do?structureId=6hcl RCSB], [http://www.ebi.ac.uk/pdbsum/6hcl PDBsum], [http://prosat.h-its.org/prosat/prosatexe?pdbcode=6hcl ProSAT]</span></td></tr> | |||
</table> | |||
<div style="background-color:#fffaf0;"> | |||
== Publication Abstract from PubMed == | |||
In human and other mammalian cells, transport of L-lactate across plasma membranes is mainly catalyzed by monocarboxylate transporters (MCTs) of the SLC16 solute carrier family. MCTs play an important role in cancer metabolism and are promising targets for tumor treatment. Here, we report the crystal structures of an SLC16 family homologue with two different bound ligands at 2.54 and 2.69 A resolution. The structures show the transporter in the pharmacologically relevant outward-open conformation. Structural information together with a detailed structure-based analysis of the transport function provide important insights into the molecular working mechanisms of ligand binding and L-lactate transport. | |||
Mechanistic basis of L-lactate transport in the SLC16 solute carrier family.,Bosshart PD, Kalbermatter D, Bonetti S, Fotiadis D Nat Commun. 2019 Jun 14;10(1):2649. doi: 10.1038/s41467-019-10566-6. PMID:31201333<ref>PMID:31201333</ref> | |||
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.<br> | |||
[[Category: | </div> | ||
<div class="pdbe-citations 6hcl" style="background-color:#fffaf0;"></div> | |||
== References == | |||
<references/> | |||
__TOC__ | |||
</StructureSection> | |||
[[Category: Large Structures]] | |||
[[Category: Bonetti, S]] | |||
[[Category: Bosshart, P]] | |||
[[Category: Fotiadis, D]] | |||
[[Category: Kalbermatter, D]] | |||
[[Category: Membrane protein]] | |||
[[Category: Mfs transporter]] | |||
Latest revision as of 08:47, 3 July 2019
Crystal structure of a MFS transporter with Ligand at 2.69 Angstroem resolutionCrystal structure of a MFS transporter with Ligand at 2.69 Angstroem resolution
Structural highlights
Publication Abstract from PubMedIn human and other mammalian cells, transport of L-lactate across plasma membranes is mainly catalyzed by monocarboxylate transporters (MCTs) of the SLC16 solute carrier family. MCTs play an important role in cancer metabolism and are promising targets for tumor treatment. Here, we report the crystal structures of an SLC16 family homologue with two different bound ligands at 2.54 and 2.69 A resolution. The structures show the transporter in the pharmacologically relevant outward-open conformation. Structural information together with a detailed structure-based analysis of the transport function provide important insights into the molecular working mechanisms of ligand binding and L-lactate transport. Mechanistic basis of L-lactate transport in the SLC16 solute carrier family.,Bosshart PD, Kalbermatter D, Bonetti S, Fotiadis D Nat Commun. 2019 Jun 14;10(1):2649. doi: 10.1038/s41467-019-10566-6. PMID:31201333[1] From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine. References
|
| ||||||||||||||||||